Frankfurt (9 February 2022) –MV Index Solutions GmbH (MVIS®) today announced the launch of the MVIS Global Bionic Healthcare ESG Index (ticker: MVBION) .

The MVIS Global Bionic Healthcare ESG Index (ticker: MVBION) includes companies that generate at least 50% of their revenue from medical, dental or vision-related implants, bioprinting, prosthesis or preservation of organs and tissue.

“We are excited to announce the launch of the MVIS Global Bionic Healthcare ESG Index today. This index is designed to reflect the bionic implants market, in which the growth is expected to be driven by aging population with higher disposable income worldwide and the expanding medical technology and scientific innovations. The index offers investors an investable benchmark capturing the leading companies in this sector,” said Mirela Stefanova, Manager Equity Operations at MV Index Solutions.

The MVIS Global Bionic Healthcare ESG Index (ticker: MVBION) is weighted by free float market capitalisation and reviewed on a quarterly basis. The index is calculated in USD as a price index and a total return net index. Capping factors are applied to avoid overweighting of single index components.

Detailed information about the Indices, including methodology details and index data, is available on the MV Index Solutions website.

Press Release

Most popular